PRESS RELEASES
IQ Biometrix appoints Morden C. Lazarus
to Chairman of the Board of Directors
CUPERTINO, Calif.,Feb. 21, 2003
IQ Biometrix Inc. IQBM, a worldwide provider of integrated
law enforcement and security solutions, announced today
the appointment of Morden C. Lazarus to the position of
Chairman of the Board of Directors.
"Mr. Lazarus will help IQ Biometrix
accelerate its entry into new markets, including private
sector security," said CEO William Scigliano. "The
appointment is part of our strategy to build on our foundation
technologies and partnerships to provide customized, integrated
responses to both law enforcement and security needs."
Former Chair Eric McAfee will continue to
serve on the IQ Biometrix Board of Directors.
Morden C. Lazarus founded the law firm of
Lazarus Charbonneau in 1967. He has acted as legal counsel
to the Royal Bank of Canada for a period in excess of 25
years. He has acted as legal counsel to many casino properties
and is the only Canadian gaming lawyer to have been appointed
a member of the Board of Trustees of the International Association
of Gaming Attorneys ("IAGA"), based in Las Vegas,
Nevada. He was named Secretary of "IAGA" in September
of 2002 and will occupy the office of President of "IAGA"
in the fall of 2004.
He is a member of the Board of Directors
of DPC Biosciences Corporation, a public company, whose
shares are traded on TSX ("Toronto Venture Stock Exchange"),
Anchor Gaming (Canada) Inc. and United Tote (Canada) Inc.,
subsidiaries of International Game Technology (IGT). He
is also presently chairman and CEO of ISee3D Inc. (formerly
"International Telepresence (Canada) Inc."), a
public company, whose shares are traded on the TSX. In the
past, he was appointed by the Quebec Cabinet to the Board
of Directors and executive committee of Soci?t? de d?veloppement
industriel du Qu?bec (now "Investissement Qu?bec"),
the province?s largest Crown corporation, where he served
for approximately six years.
Mr. Lazarus is associated with many charitable
groups and institutions. He is a past recipient of the "Man
of the Year" award for the Juvenile Diabetes Foundation.
For more information please see the CEO
letter recently posted at the Company's Web site, www.iqbiometrix.com.
Except for historical information, the matters
set forth herein which are forward-looking statements involve
certain risks and uncertainties that could cause actual
results to differ. Potential risks and uncertainties include,
but are not limited to, the level of government, business
and consumer spending for computer software; the market
acceptance and amount of sales of the Company's products;
the competitive environment within the facial recognition
software industry, the Company's ability to raise additional
capital, the extent and cost-effectiveness with which the
Company is able to develop, acquire or license marketable
products, and the market acceptance and successful technical
and economic implementation of the Company's programs. Investors
are directed to consider other risks and uncertainties in
documents including, forms 8K and 10QSB, filed by the Company
with the Securities and Exchange Commission, www.sec.gov.
Contact Information:
IQ Biometrix Inc.
Media Contact:
Greg Micek, 888/321-5553
or
Investor Contact:
Equity Communications
Robert Schechter, 212/499-6809
Back
to Press Releases
